Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Long-term protection of central axons with phenytoin in monophasic and chronic-relapsing EAE.
Longitudinally extensive transverse myelitis with anti-NMDA receptor antibodies during a systemic lupus erythematosus flare-up.
Report of Three Cases of Herpes Zoster During Treatment with Natalizumab.
Parallel states of pathological Wnt signaling in neonatal brain injury and colon cancer.
Can smoking aggravate my multiple sclerosis symptoms?
Characterization of natural killer cells in paired CSF and blood samples during neuroinflammation.
Natalizumab affects the T-cell receptor repertoire in patients with multiple sclerosis.
Cognitive Impairment Has a Strong Relation to Nonsomatic Symptoms of Depression in Relapsing-Remitting Multiple Sclerosis.
Natalizumab is effective in multiple sclerosis patients switching from other disease modifying therapies in clinical practice.
Janus-like opposing roles of CD47 in autoimmune brain inflammation in humans and mice.
Progressive multifocal leukoencephalopathy: new concepts.
Endogeneous Remyelination: Findings in Human Studies.
Phenytoin for neuroprotection in patients with acute optic neuritis: a randomised, placebo-controlled, phase 2 trial.
Simvastatin in acute optic neuritis.
Interferon regulatory factor 5 gene variants and pharmacological and clinical outcome of Interferonb therapy in multiple sclerosis.
Conditional DC depletion does not affect priming of encephalitogenic Th cells in EAE.
Multiple sclerosis and bipolar disorders: The burden of comorbidity and its consequences on quality of life.
From classic to spontaneous and humanized models of multiple sclerosis: Impact on understanding pathogenesis and drug development.
A Large-Scale Study of Anxiety and Depression in People with Multiple Sclerosis: A Survey via the Web Portal of the UK MS Register.
JCV GCN in a natalizumab-treated MS patient is associated with mutations of the VP1 capsid gene.
Newly diagnosed multiple sclerosis in state of Qatar.
Smoking induces long-lasting effects through a monoamine-oxidase epigenetic regulation.
The effect of the interval-between-sessions on prefrontal transcranial direct current stimulation (tDCS) on cognitive outcomes: a systematic review and meta-analysis.
Clinical Assessment of Orofacial Manifestations in 500 Patients With Multiple Sclerosis.
Network analysis of transcriptional regulation in response to intramuscular interferon-β-1a multiple sclerosis treatment.
Pages
« first
‹ previous
…
140
141
142
143
144
145
146
147
148
…
next ›
last »